Actor Carlos Ponce joins Cigna at the 2019 Walt Disney World® 5K to encourage Latinos to take control of their physical and emotional wellbeing
ORLANDO, Fla., Jan. 11, 2019 /PRNewswire/ -- Actor Carlos Ponce joined Cigna at the 2019 Walt Disney World® 5K in Orlando, FL to support Cigna's mission to help the Hispanic community take control of their health. Through this partnership, Cigna and Carlos are working together to encourage preventive care by educating individuals on how to take steps toward being their best selves, physically and emotionally. That includes getting your annual check-up, talking openly and honestly about how you are feeling and knowing your four health numbers (cholesterol, blood pressure, blood sugar, and body mass index), which are responsible for the majority of chronic conditions. Together, Cigna and Carlos Ponce hope to motivate you go to your annual check-up and talk to your doctor, so you can understand what changes will help you make healthier choices that will positively affect your lifestyle.
Carlos shared, "I am starting the year on the right foot collaborating with Cigna, inviting everyone to pay attention to their bodies and emotions. Getting an annual check-up and learning your four numbers health numbers is very important because it can help us prevent bigger problems."
Visit Cigna.com/takecontrol for more information.
Media Contact: Shen Williams, [email protected] Social Information: @Cigna_espanol, @Cignaenespanol
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that updated Phase 1/2 data for AU-007 will be presented at the American Society...
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...
Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase 2 study of PRGN-2012 AdenoVerse immunotherapy...
The two poster presentations will report -first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy armcombination data from the...
Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Kwan-Ho "Alex" Chung, Ph.D. has joined the firm's Intellectual Property practice group and Life Sciences industry team in Washington, D.C. Chung was most recently a partner at...
For nearly 40 years Burke Williams has been an innovator and leader in the luxury day spa industry, and in 2024 the company is continuing to deliver relaxing, rejuvenating experiences for guests that truly transform their day....